[Correlation between pregnancy complications and congenital malformations in the newborn infant].
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D050260:Carbohydrate Metabolism; D000013:Congenital Abnormalities / Q000209:etiology*; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D006939:Hyperemesis Gravidarum / Q000150:complications / Q000188:drug therapy; D007231:Infant, Newborn; D007674:Kidney Diseases / Q000188:drug therapy; D008431:Maternal-Fetal Exchange; D010208:Papaverine / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011374:Progesterone / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use
D014149:Tranquilizing Agents; D011374:Progesterone; D010208:Papaverine
Sur la corrélation entre la dysgravidie et les malformations congénitales du nouveau-né.